Arizona Medicaid and semaglutide
Wegovy for weight loss: no. AHCCCS says it covers Wegovy in specific circumstances to reduce heart risk, when medically necessary and with prior authorization. Status as of November 2025. Ozempic for weight loss: no. AHCCCS says GLP-1 is not covered for obesity. For type 2 diabetes, members must have a documented failure of non GLP-1 treatment such as metformin. Status as of November 2025.; for type 2 diabetes Arizona Medicaid must cover it. Read from Arizona Health Care Cost Containment System documents Nov 6, 2026.
Wegovy · AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report
“AHCCCS currently does not cover GLP-1 for the treatment of obesity.”
read Nov 6, 2026
Wegovy · AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report
“AHCCCS also covers 1 GLP-1 Receptor Agonist (Wegovy) in specific circumstances to reduce the risk of major adverse cardiovascular events when medically necessary and approved via prior authorization.”
read Nov 6, 2026
Ozempic · AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report
“For the treatment of type 2 diabetes, members must have a documented failure of non GLP-1 treatments (metformin).”
read Nov 6, 2026
In 2025 Arizona Medicaid paid for 8,154 semaglutide prescriptions (Ozempic, Wegovy, Rybelsus), 8.7% of its GLP-1 prescriptions and 47th of the 50 states and DC. It reimbursed $7.1 million before rebates, $874 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 6,974 | $5.9 million | $848 |
| Wegovy | 865 | $929,354 | $1,074 |
| Rybelsus | 315 | $285,342 | $906 |
Arizona plans and prescribing rules
Blue Cross Blue Shield of Arizona (AZ Blue). AZ Blue's August 2024 provider notice says GLP-1s approved for type 2 diabetes, such as Ozempic, are covered only for that purpose and not for weight-loss management, across its group and individual plans, from September 1, 2024. The notice does not address Wegovy or Zepbound.
Semaglutide in the states around Arizona
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Arizona | 19 | $39/moWellmedr | 8,154 | Medicaid Wegovy: No |
| California | 17 | $39/moWellmedr | 2,000,893 | Medicaid Wegovy: No |
| Colorado | 19 | $39/moWellmedr | 26,771 | Medicaid Wegovy: No |
| Nevada | 19 | $39/moWellmedr | 44,949 | Medicaid Wegovy: No |
| New Mexico | 19 | $39/moWellmedr | 39,521 | Medicaid Wegovy: No |
| Utah | 19 | $39/moWellmedr | 10,366 | Medicaid Wegovy: Not confirmed (KFF) |



